Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

  • This share is currently suspended. It was suspended at a price of 9.75
  • There is currently no data for INHC

Form 8.5 (EPT/RI)

24 Apr 2025 10:22

RNS Number : 0543G
Singer Capital Markets Sec Ltd
24 April 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Induction Healthcare Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Induction Healthcare Group Plc

(d) Date dealing undertaken:

23 April 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.5P

 

Purchases

 

1,305,000

 

9.5p

 

9.5p

 

ORD 0.5P

 

Sales

 

1,253,000

 

9.6p

 

9.6p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

24 April 2025

Contact name:

Jennifer Bentick 

Telephone number:

020 7496 3055

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUSUKRVAUSURR
Date   Source Headline
17th Apr 20253:00 pmRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 20253:00 pmRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 202511:55 amRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 202510:51 amRNSForm 8.5 (EPT/RI)
17th Apr 20257:00 amRNSPublication of Scheme Document
16th Apr 202510:50 amRNSForm 8.5 (EPT/RI)
11th Apr 20252:29 pmEQSForm 8.3 - Induction Healthcare Group PLC - Opening Position Disclosure
11th Apr 202511:46 amRNSForm 8.5 (EPT/RI)
11th Apr 202511:14 amRNSForm 8.3 - Induction Healthcare Group Plc
10th Apr 202512:45 pmRNSRecommended Cash Acquisition
9th Apr 20256:15 pmRNSDirectorate Change
28th Jan 20257:00 amRNSBlock listing Interim Review
2nd Dec 20247:00 amRNSNew Contract in Republic of Ireland
5th Nov 20247:00 amRNSHalf-year Report
30th Oct 20247:00 amRNSMaterial new contract & Notice of Interim Results
13th Aug 20241:29 pmRNSResult of AGM
29th Jul 202410:00 amRNSBlock Listing Six Monthly Return
17th Jul 20247:00 amRNSGrant of Options
4th Jul 20247:00 amRNSFinal Results
1st Jul 202411:07 amRNSAMENDMENT: DIVESTMENT OF HORIZON
1st Jul 20247:00 amRNSDIVESTMENT OF HORIZON STRATEGIC PARTNERS LIMITED
27th Jun 20247:00 amRNSPublication of Full Year Financial Results Delayed
29th Apr 20247:00 amRNSFull Year Trading Update
29th Jan 20247:00 amRNSBlock listing Interim Review
7th Nov 20237:00 amRNSHalf-year Report
10th Oct 20237:00 amRNSUpdate on NHS National Portals Contracts
31st Jul 20233:13 pmRNSBlock listing Interim Review
31st Jul 20237:00 amRNSAudited Final Results
30th Jun 20237:00 amRNSBoard Changes and Trading Update
18th Apr 20237:00 amRNSTrading Update for year ending 31 March 2023
27th Jan 20237:00 amRNSBlock Listing Six Monthly Return
17th Jan 20237:00 amRNSChange of Registered Office
16th Jan 202312:20 pmRNSDirector/PDMR Shareholding
11th Jan 202312:52 pmRNSResults of 2022 Annual General Meeting
9th Jan 20237:00 amRNSDirectorate Changes
20th Dec 20227:00 amRNSChange of Auditor
20th Dec 20227:00 amRNSNotice of AGM
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20227:01 amRNSDirectorate Changes
5th Dec 20227:00 amRNSHalf-year Report
29th Nov 202212:01 pmEQSInduction Healthcare Group focused on 'building out core capability'
28th Nov 20227:01 amRNSNotice of Half-year results
28th Nov 20227:00 amRNSAudited Final Results
24th Oct 20227:00 amRNSUpdate on publication of Audited Final Results
22nd Sep 20227:00 amRNSExtension to 2022 annual reporting deadline

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.